AI ECG to guide heart medication for normal pump function
Part of Heart & circulation clinical trials.
This study uses an AI-enhanced ECG to guide doctors in prescribing heart medications and aims to prevent future heart-pumping problems. It may help you if your heart function is currently normal and you have recent heart tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had an ECG and an echocardiogram within 90 days of each other.
- Your heart pump function (LVEF) is currently 50% or higher.
- You have never had a heart pump function below 50% in the past.
- You are not lost to follow-up or deceased during the 90-day assessment period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an artificial intelligence (AI) program can detect a weak heart pump (left ventricular dysfunction) using a standard ECG test. It aims to see if the AI can spot problems early, possibly avoiding the need for an ultrasound.
This trial uses an AI tool to analyze your ECG (heart tracing) to detect low pumping function. It may help find hidden heart issues early, especially if you haven't had a recent heart ultrasound.
This trial is testing how well an AI tool can help doctors diagnose aortic stenosis and diastolic dysfunction by analyzing your scheduled ECG (heart test). The study takes place during your routine care at the clinic.
This trial uses artificial intelligence to analyze your ECG to see if you might be at risk for needing a heart device like a pacemaker. It's a way to check your heart health early.
This study tests whether an artificial intelligence system can detect a weakened heart pump using an ECG (heart rhythm test). If successful, it could help doctors diagnose heart problems faster and more easily.
This study uses an AI tool to look at your ECG (a simple heart test) to help find early signs of atrial fibrillation (an irregular heartbeat) or structural heart disease (changes in heart structure). It aims to see if the AI can help doctors catch these conditions sooner, even in people who don't yet have symptoms.
Hear when a new Left Ventricular (LV) Systolic Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.